| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
Bryostatin 1 |
FIMM |
pan-cancer |
AAC |
0.01 |
0.9 |
| mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
0.9 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |